Phase II study of the HSP90 inhibitor AUY922 in patients with previously treated, advanced non-small cell lung cancer (NSCLC).
Edward B. Garon
Research Funding - Novartis
Teresa Moran
No relevant relationships to disclose
Fabrice Barlesi
Honoraria - Novartis; Novartis
Research Funding - Novartis; Novartis
Leena Gandhi
No relevant relationships to disclose
Lecia V. Sequist
Consultant or Advisory Role - Celgene; Clovis Oncology; Daiichi Sankyo (U); GlaxoSmithKline; Merrimack (U)
Sang-We Kim
No relevant relationships to disclose
Harry J.M. Groen
No relevant relationships to disclose
Benjamin Besse
No relevant relationships to disclose
Egbert F Smit
No relevant relationships to disclose
Dong-Wan Kim
No relevant relationships to disclose
Mikhail Akimov
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Emin Avsar
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Stuart Bailey
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Enriqueta Felip
No relevant relationships to disclose